您当前的位置: 首页 > 数据库
  • 全部(1880)
  • 腹部手术(323)
  • 胸科手术(41)
  • 血管手术(5)
  • 心脏手术(56)
  • 神经外科(4)
  • 头颈部(35)
  • 骨科(78)
  • 泌尿外科(0)
  • 妇产手术(56)
  • 日间手术(26)
  • 手术室外(0)
  • 创伤和烧伤(0)
  • 非心脏手术(410)
  • 老年(0)
  • 小儿新生儿(126)
  • 特殊患者(42)
  • 未说明手术类型(678)
  • 术前宣教(21)
  • 术前评估(33)
  • 术前用药(15)
  • 术前禁食水(12)
  • 麻醉选择(21)
  • 麻醉用药(10)
  • 术中监测(23)
  • 液体管理(14)
  • 血液保护(3)
  • 体温管理(8)
  • 术后疼痛(43)
  • POD(8)
  • PONV(10)
  • 术后康复(50)
  • 特殊情况(43)
  • 术前肠道准备(9)
Array ( [id] => 1348 [catid] => 297 [title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/1348.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:24:30 [updatetime] => 2024-01-11 15:24:30 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2023 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => Prophylactic administration of fibrinogen concentrate is not recommended in prostate surgery. (Evidence level: low;Recommendation grade:strong) [laiyuan] => 在前列腺手术中不推荐预防性使用纤维蛋白原浓缩物。(证据级别:低;推荐强度:强推荐) [znzldj] => B [_inputtime] => 1704957870 [_updatetime] => 1704957870 [_nrjc] => [_nrsh] => )
推荐意见
在前列腺手术中不推荐预防性使用纤维蛋白原浓缩物。(证据级别:低;推荐强度:强推荐)

Prophylactic administration of fibrinogen concentrate is not recommended in prostate surgery. (Evidence level: low;Recommendation grade:strong)

证据评价方法:GRADE

指南质量等级:B

年份:2023

国家:the European Society of Anaesthesiology and Intens

阅读
Array ( [id] => 1349 [catid] => 297 [title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/1349.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:24:30 [updatetime] => 2024-01-11 15:24:30 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2023 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => Computed tomography scan or angiography are suggested for the diagnosis of late bleeding after pancreatectomy, and endovascular interventional therapy is suggested as primary treatment. (Evidence level: low;Recommendation grade:weak) [laiyuan] => 胰腺切除术后迟发性出血的诊断建议行CT或血管造影检查,血管内介入治疗为首选治疗方法。(证据级别:低;推荐强度:弱推荐) [znzldj] => B [_inputtime] => 1704957870 [_updatetime] => 1704957870 [_nrjc] => [_nrsh] => )
推荐意见
胰腺切除术后迟发性出血的诊断建议行CT或血管造影检查,血管内介入治疗为首选治疗方法。(证据级别:低;推荐强度:弱推荐)

Computed tomography scan or angiography are suggested for the diagnosis of late bleeding after pancreatectomy, and endovascular interventional therapy is suggested as primary treatment. (Evidence level: low;Recommendation grade:weak)

证据评价方法:GRADE

指南质量等级:B

年份:2023

国家:the European Society of Anaesthesiology and Intens

阅读
Array ( [id] => 1350 [catid] => 297 [title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/1350.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:24:30 [updatetime] => 2024-01-11 15:24:30 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2023 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => Preoperative chronic antithrombotic therapy and perioperative chemical thromboprophylaxis seem not to increase the peri-operative haemorrhagic complications in patients undergoing HPB surgery. (Evidence level: low) [laiyuan] => 术前长期抗栓治疗和围手术期预防性化学血栓治疗不会增加HPB患者围手术期出血并发症的发生。(证据级别:低) [znzldj] => B [_inputtime] => 1704957870 [_updatetime] => 1704957870 [_nrjc] => [_nrsh] => )
推荐意见
术前长期抗栓治疗和围手术期预防性化学血栓治疗不会增加HPB患者围手术期出血并发症的发生。(证据级别:低)

Preoperative chronic antithrombotic therapy and perioperative chemical thromboprophylaxis seem not to increase the peri-operative haemorrhagic complications in patients undergoing HPB surgery. (Evidence level: low)

证据评价方法:GRADE

指南质量等级:B

年份:2023

国家:the European Society of Anaesthesiology and Intens

阅读
Array ( [id] => 1351 [catid] => 297 [title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/1351.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:24:30 [updatetime] => 2024-01-11 15:24:30 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2023 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => We suggest that cell salvage is not contraindicated in cancer surgery, provided that blood aspiration close to the tumour site is avoided and leukodepletion filters are used. (Evidence level: low;Recommendation grade:weak) [laiyuan] => 我们认为,在肿瘤手术中,只要避免靠近肿瘤部位的血液抽吸,并使用白细胞清除滤器,细胞回收并不禁忌。(证据级别:低;推荐强度:弱推荐) [znzldj] => B [_inputtime] => 1704957870 [_updatetime] => 1704957870 [_nrjc] => [_nrsh] => )
推荐意见
我们认为,在肿瘤手术中,只要避免靠近肿瘤部位的血液抽吸,并使用白细胞清除滤器,细胞回收并不禁忌。(证据级别:低;推荐强度:弱推荐)

We suggest that cell salvage is not contraindicated in cancer surgery, provided that blood aspiration close to the tumour site is avoided and leukodepletion filters are used. (Evidence level: low;Recommendation grade:weak)

证据评价方法:GRADE

指南质量等级:B

年份:2023

国家:the European Society of Anaesthesiology and Intens

阅读
Array ( [id] => 1296 [catid] => 297 [title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/1296.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:24:29 [updatetime] => 2024-01-11 15:24:29 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2023 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => Withdrawal of aspirin treatment before surgery might increase the risk of coronary thrombosis; however, continuation of aspirin treatment increases the risk of bleeding.(Evidence level: moderate) [laiyuan] => 在手术前停止阿司匹林治疗可能会增加冠状动脉血栓形成的风险;然而,持续阿司匹林治疗会增加出血的风险。(证据级别:中) [znzldj] => B [_inputtime] => 1704957869 [_updatetime] => 1704957869 [_nrjc] => [_nrsh] => )
推荐意见
在手术前停止阿司匹林治疗可能会增加冠状动脉血栓形成的风险;然而,持续阿司匹林治疗会增加出血的风险。(证据级别:中)

Withdrawal of aspirin treatment before surgery might increase the risk of coronary thrombosis; however, continuation of aspirin treatment increases the risk of bleeding.(Evidence level: moderate)

证据评价方法:GRADE

指南质量等级:B

年份:2023

国家:the European Society of Anaesthesiology and Intens

阅读
Array ( [id] => 1297 [catid] => 297 [title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/1297.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:24:29 [updatetime] => 2024-01-11 15:24:29 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2023 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => Withdrawal of treatment with P2Y12 inhibitors (clopidogrel, prasugrel and ticagrelor) before surgery might increase the risk of coronary thrombosis; however, continuation of clopidogrel therapy increases the risk of bleeding.(Evidence level: moderate) [laiyuan] => 术前停用P2Y12抑制剂(氯吡格雷、普拉格雷和替卡格雷)可能会增加冠状动脉血栓形成的风险;然而,继续氯吡格雷治疗会增加出血的风险。(证据级别:中) [znzldj] => B [_inputtime] => 1704957869 [_updatetime] => 1704957869 [_nrjc] => [_nrsh] => )
推荐意见
术前停用P2Y12抑制剂(氯吡格雷、普拉格雷和替卡格雷)可能会增加冠状动脉血栓形成的风险;然而,继续氯吡格雷治疗会增加出血的风险。(证据级别:中)

Withdrawal of treatment with P2Y12 inhibitors (clopidogrel, prasugrel and ticagrelor) before surgery might increase the risk of coronary thrombosis; however, continuation of clopidogrel therapy increases the risk of bleeding.(Evidence level: moderate)

证据评价方法:GRADE

指南质量等级:B

年份:2023

国家:the European Society of Anaesthesiology and Intens

阅读
Array ( [id] => 1298 [catid] => 297 [title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/1298.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:24:29 [updatetime] => 2024-01-11 15:24:29 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2023 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => In patients on DAPT who need to undergo nonemergency cardiac surgery, postponing surgery for at least 5 days after discontinuation of ticagrelor or clopidogrel and 7 days after prasugrel should be considered.(Evidence level: moderate;Recommendation grade: weak) [laiyuan] => 对于需要进行非紧急心脏手术的双重抗血小板治疗患者,停用替格瑞洛或氯吡格雷后至少推迟5天,普拉格雷7天后考虑手术。(证据级别:中;推荐强度:弱推荐) [znzldj] => B [_inputtime] => 1704957869 [_updatetime] => 1704957869 [_nrjc] => [_nrsh] => )
推荐意见
对于需要进行非紧急心脏手术的双重抗血小板治疗患者,停用替格瑞洛或氯吡格雷后至少推迟5天,普拉格雷7天后考虑手术。(证据级别:中;推荐强度:弱推荐)

In patients on DAPT who need to undergo nonemergency cardiac surgery, postponing surgery for at least 5 days after discontinuation of ticagrelor or clopidogrel and 7 days after prasugrel should be considered.(Evidence level: moderate;Recommendation grade: weak)

证据评价方法:GRADE

指南质量等级:B

年份:2023

国家:the European Society of Anaesthesiology and Intens

阅读
Array ( [id] => 1299 [catid] => 297 [title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/1299.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:24:29 [updatetime] => 2024-01-11 15:24:29 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2023 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => Platelet function testing may be considered to guide the decision on the timing of cardiac surgery in patients who have recently received P2Y12 inhibitors.(Evidence level: moderate) [laiyuan] => 血小板功能检测可以指导近期接受P2Y12抑制剂治疗的患者决定心脏手术的时机。(证据级别:中) [znzldj] => B [_inputtime] => 1704957869 [_updatetime] => 1704957869 [_nrjc] => [_nrsh] => )
推荐意见
血小板功能检测可以指导近期接受P2Y12抑制剂治疗的患者决定心脏手术的时机。(证据级别:中)

Platelet function testing may be considered to guide the decision on the timing of cardiac surgery in patients who have recently received P2Y12 inhibitors.(Evidence level: moderate)

证据评价方法:GRADE

指南质量等级:B

年份:2023

国家:the European Society of Anaesthesiology and Intens

阅读
Array ( [id] => 1300 [catid] => 297 [title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/1300.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:24:29 [updatetime] => 2024-01-11 15:24:29 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2023 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => Bridging oral antiplatelet therapy with LMWH is not recommended.(Evidence level:high;Recommendation grade: strong) [laiyuan] => 不推荐口服低分子肝素进行桥接抗血小板治疗。(证据级别:高;推荐强度:强推荐) [znzldj] => B [_inputtime] => 1704957869 [_updatetime] => 1704957869 [_nrjc] => [_nrsh] => )
推荐意见
不推荐口服低分子肝素进行桥接抗血小板治疗。(证据级别:高;推荐强度:强推荐)

Bridging oral antiplatelet therapy with LMWH is not recommended.(Evidence level:high;Recommendation grade: strong)

证据评价方法:GRADE

指南质量等级:B

年份:2023

国家:the European Society of Anaesthesiology and Intens

阅读
Array ( [id] => 1301 [catid] => 297 [title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/1301.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:24:29 [updatetime] => 2024-01-11 15:24:29 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2023 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => We suggest that aspirin or P2Y12 inhibitors may be administered in the early postoperative period without increasing the risk of postoperative bleeding.(Evidence level: low;Recommendation grade: weak) [laiyuan] => 我们建议在术后早期使用阿司匹林或P2Y12抑制剂,不会增加术后出血的风险。(证据级别:低;推荐强度:弱推荐) [znzldj] => B [_inputtime] => 1704957869 [_updatetime] => 1704957869 [_nrjc] => [_nrsh] => )
推荐意见
我们建议在术后早期使用阿司匹林或P2Y12抑制剂,不会增加术后出血的风险。(证据级别:低;推荐强度:弱推荐)

We suggest that aspirin or P2Y12 inhibitors may be administered in the early postoperative period without increasing the risk of postoperative bleeding.(Evidence level: low;Recommendation grade: weak)

证据评价方法:GRADE

指南质量等级:B

年份:2023

国家:the European Society of Anaesthesiology and Intens

阅读